References
- Bucaretchi F, Vicente DC, Pereira RM, Tresoldi AT. 2004; Dapsone hypersensitivity syndrome in an adolescent during treatment of leprosy.. Rev Inst Med Trop Sao Paulo. 46:331–4.
- Mohle-Boetani J, Akula SK, Holodniy M, Katzenstein D, Garcia G. 1992; The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West J Med. 156:303–6.
- Rao PN, Lakshmi TS. 2001; Increase in the incidence of dapsone hypersensitivity syndrome-An appraisal. Lepr Rev. 72:57–62.
- Lowe J, Smith M. 1949; The chemotherapy of leprosy in Nigeria; with an appendix on glandular fever and exfoliative dermatitis precipitated by sulfones. Int J Lepr. 17:181–95.
- Vanderborght PR, Pacheco AG, Moraes ME, Antoni G, Romero M, Verville A, 2007; HLA-DRB1∗04 and DRB1∗10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun. 8:320–4.
- Deps PD, Nasser S, Guerra P, Simon M, Birshner Rde C, Rodrigues LC. 2007; Adverse effects from multi-drug therapy in leprosy: a Brazilian study. Lepr Rev. 78:216–22.
- Reeve PA, Ala J, Hall JJ. 1992; Dapsone syndrome in Vanuatu: A high incidence during multidrug treatment (MDT) of leprosy. J Trop Med Hyg. 95:266–70.
- Richardus JH, Smith TC. 1989; Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy. Lepr Rev. 60:267–73.
- Prussick R, Shear NH. 1996; Dapsone hypersensitivity syndrome. J Am Acad Dermatol. 35:(2 Pt 2)346–9.
- Agrawal S, Agarwalla A. 2005; Dapsone hypersensitivity syndrome: A clinico-epidemiological review. J Dermatol. 32:883–9.
- Kosseifi SG, Guha B, Nassour DN, Chi DS, Krishnaswamy G. 2006; The Dapsone hypersensitivity syndrome revisited: A potentially fatal multisystem disorder with prominent hepatopulmonary manifestations. J Occup Med Toxicol. 1:9.
- Pandey B, Shrestha K, Lewis J, Hawksworth RA, Walker SL. 2007; Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Trop Doct. 37:162–3.
- Johnson DA, Cattau ELJr, Kuritsky JN, Zimmerman HJ. 1986; Liver involvement in the sulfone syndrome. Arch Intern Med. 146:875–7.
- Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, 2007; Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 157:934–40.
- Lau G. 1995; A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: Dapsone syndrome or rifampicin toxicity?. Forensic Sci Int. 73:109–15.